ATP6v0d2 Knockout IBMDM Cell Line
Cat.No.:
EDC07919
Species:
Mouse
Cell Name:
IBMDM
Gene:
ATP6v0d2
Gene ID:
242341
Size:
1×10⁶cells
ATP6v0d2 Knockout IBMDM Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07919 |
|---|---|
| Product Name | ATP6v0d2 Knockout IBMDM Cell Line |
| Species | Mouse |
| Cell Line | IBMDM |
| Gene |
ATP6v0d2
|
| Gene ID | |
| Associated Diseases | Non-tumor |
| Digestion Time | / |
| Morphology | Semi-Suspension, Semi-Adherent |
| Passage Ratio | 1:5,2 days |
| Complete Culture Medium | DMEM+10% FBS |
| Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
FAQ
Is this Atp6v0d2 Knockout IBMDM Cell Line compatible with overexpression rescue experiments?
Yes. ATP6V0D2 rescue experiments require attention to V-ATPase assembly:
• Construct design: use a codon-modified Atp6v0d2 sequence with a small C-terminal tag (FLAG, HA). ATP6V0D2 is a small V0 subunit (~40 kDa) — preserve protein integrity.
• V-ATPase assembly: rescue interpretation considers other V0 and V1 sector subunits for proper holoenzyme assembly.
• Functional readout: rescue should restore tissue-specific V-ATPase composition and acidification.
IBMDM-specific considerations:
• IBMDM is an immortalized murine bone marrow-derived macrophage cell line, providing a renewable myeloid context for innate immunity and inflammasome research.
• Lentiviral transduction is supported with moderate efficiency.
• Macrophage activation (LPS, IFN-γ priming) should be characterized before inflammasome and antimicrobial response assays.
What are the application scenarios for this model?
Primary applications:
• Tissue-specific V-ATPase composition: V0 sector subunit analysis in ATP6V0D2-null cells.
• Lysosomal acidification: lysosomal pH analysis in ATP6V0D2-null macrophages.
• ATP6V0D1 paralog studies: ATP6V0D1 expression analysis to interpret ATP6V0D2-specific functions.
• Macrophage biology: in IBMDM context, ATP6V0D2's role in macrophage acidification.
EDITGENE recommends this IBMDM-based model for researchers investigating tissue-specific V-ATPase biology and emerging ATP6V0D2 macrophage functions.
Which is better for studying Atp6v0d2 function, Atp6v0d2 Knockout IBMDM Cell Line or Atp6v0d2 overexpression IBMDM Cell Line?
The choice depends on whether you are studying ATP6V0D2's role as a macrophage-enriched V-ATPase subunit or modeling its functions in osteoclast biology and macrophage acidification. The Knockout line is appropriate for asking whether ATP6V0D2 is required for predicted activities — ATP6V0D2 is one of two D subunit isoforms of the vacuolar (V-)ATPase V0 sector; ATP6V0D2 (vs ATP6V0D1, the broadly expressed isoform) is selectively expressed in osteoclasts, macrophages, and other specialized cells, contributing to lysosomal and resorption lacuna acidification. Overexpression is useful for studying ATP6V0D2 in heterologous expression contexts.
For osteoclast and macrophage biology research, the EDITGENE Atp6v0d2 Knockout in IBMDM is relevant — IBMDM provides a macrophage context for ATP6V0D2 study. ATP6V0D1 paralog expression analysis aids interpretation given partial functional overlap. Rescue with wild-type ATP6V0D2 is the standard specificity control. The knockout is valuable for studying tissue-specific V-ATPase composition and emerging ATP6V0D2 functions in osteoclast biology.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download